Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 118659
Published online Jun 27, 2026. doi: 10.4240/wjgs.118659
Published online Jun 27, 2026. doi: 10.4240/wjgs.118659
Table 1 Comparison of general data between the two patient groups (n = 40), n (%)/mean ± SD
| Group | Gender | Age (years) | Type 2 diabetes mellitus duration (years) | Number of glucose-lowering agents | ||
| Male | Female | Biguanides | Sulfonylureas | |||
| Control group | 24 (60.00) | 16 (40.00) | 54.13 ± 2.52 | 8.33 ± 1.75 | 40 | 27 (67.50) |
| Observation group | 21 (52.50) | 19 (47.50) | 54.05 ± 3.26 | 8.53 ± 1.91 | 40 | 23 (57.50) |
| Test statistic | 0.457 | 0.115 | -0.489 | - | 0.853 | |
| P value | 0.499 | 0.909 | 0.626 | - | 0.356 | |
- Citation: Li JP, Wang L, Dong L, Bai C. Impact of semaglutide with sleeve gastrectomy on blood glucose control and metabolism in obese type 2 diabetics. World J Gastrointest Surg 2026; 18(6): 118659
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/118659.htm
- DOI: https://dx.doi.org/10.4240/wjgs.118659